Skip to main content
ACG 2025 Annual Meeting Main banner
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Award Winner
ACG Newsworthy Abstract
ACG Newsworthy Abstract
ACG Health Equity Research Abstract of Distinction Award
ACG Health Equity Research Abstract of Distinction Award
Registration Required
Registration Required
No CME
No CME
On-Demand Video
On-Demand Video
Livestream
Livestream

Monday Poster Session

Category: Diet, Nutrition, and Obesity

Hypodermisin: A Novel Biomarker Associated With Obesity Identified Through <i>In Vivo</i> Protein Trafficking

P2698 - Hypodermisin: A Novel Biomarker Associated With Obesity Identified Through In Vivo Protein Trafficking

Monday, October 27, 2025
10:30 AM - 4:00 PM PDT
Location: Exhibit Hall
Michael Banki, BS, Gaurie Gunasekaran, BS, Emily Huynh, BS, Ricard Carbonell, PhD, Siyu Song, BS, Ilia Droujinine, PhD
Scripps Research, San Diego, CA

Introduction: Obesity, which currently affects over 40% of the U.S. population, may result from homeostatic dysregulation of metabolic states. The increasing prevalence of such chronic conditions highlights the need for a greater understanding of modulators influencing feeding behavior and energy balance. Interorgan signaling dysfunction from consumption of highly processed diets can overstimulate critical metabolic pathways. Investigating these communication pathways and protein trafficking can provide valuable insight into key markers involved in disease etiology and progression. Specifically, disrupting interactions between the intestine and white adipose tissue (WAT), which plays a central role in regulating systemic metabolism and energy sensing, may contribute to the development of obesity. Uncovering intestinal secreted proteins trafficked to WAT can lead to druggable targets that may attenuate the progression of obesity and related diseases.

Methods: A Cre-inducible endogenous biotin ligase (BirA*G3) affinity tracking system was developed and inserted into mice that allows for biotin-tagging intestinally secreted proteins. Proteins trafficked to 20+ organs were captured using streptavidin affinity enrichment. Mass-tag (TMT) quantitative mass spectrometry proteomics was performed, leading to the identification of hundreds of proteins trafficked from the intestinal epithelium, including GLP1/2, SST, REG3, and CCK, to various organs. Fasting time courses were conducted on mice to elucidate the crosstalk between the intestine and WAT.

Results: In this study, Hypodermisin (HPD) was identified as an intestinally secreted protein and inhibitor of hormone-induced lipolysis. The mechanism of HPD in vitro was further determined as reducing adipocyte lipolysis and promoting adipogenesis. Furthermore, an intestinal-specific HPD knockout (KO) mouse model was developed. HPD KO mice have increased glucose tolerance during fasted states, decreased insulin resistance, and heavier inguinal subcutaneous WAT with high fat diets in comparison to their controls. HPD KO mice may also have significant decreases in crown-like structures, suggesting a role in immune interplay.

Discussion: The role of HPD in obesity has previously not been characterized. This study indicates the multiple effects of HPD on metabolic processes, highlighting its potential role in obesity. Current studies investigating mechanisms of HPD in glucose tolerance and within the immune landscape are underway.

Disclosures:
Michael Banki indicated no relevant financial relationships.
Gaurie Gunasekaran indicated no relevant financial relationships.
Emily Huynh indicated no relevant financial relationships.
Ricard Carbonell indicated no relevant financial relationships.
Siyu Song indicated no relevant financial relationships.
Ilia Droujinine indicated no relevant financial relationships.

Michael Banki, BS, Gaurie Gunasekaran, BS, Emily Huynh, BS, Ricard Carbonell, PhD, Siyu Song, BS, Ilia Droujinine, PhD. P2698 - Hypodermisin: A Novel Biomarker Associated With Obesity Identified Through <i>In Vivo</i> Protein Trafficking, ACG 2025 Annual Scientific Meeting Abstracts. Phoenix, AZ: American College of Gastroenterology.